|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
|
FORM 8-K CURRENT REPORT |
|
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
May 13, 2025 |
|
(Date of Report (date of earliest event reported) |
|
IRIDEX CORPORATION |
(Exact name of registrant as specified in its charter) |
|
Delaware |
000-27598 |
77-0210467 |
(State or other jurisdiction of
incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer
Identification Number) |
1212 Terra Bella Avenue
Mountain View, California 94043 |
(Address of principal executive offices, including zip code) |
|
(650) 940-4700 |
(Registrant’s telephone number, including area code) |
(Former name or former address, if changed since last report) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of Class |
|
Trading Symbol |
|
Name of Exchange on Which Registered |
Common Stock, par value $0.01 per share |
|
IRIX |
|
Nasdaq Capital Market |
Item 2.02. Results of Operations and Financial Condition.
On May 13, 2025, IRIDEX Corporation issued a press release discussing its financial results for its first fiscal quarter ended March 29, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
IRIDEX CORPORATION |
|
|
|
|
|
By: |
|
/s/PATRICK MERCER |
|
|
|
Patrick Mercer |
|
|
|
Chief Executive Officer |
|
|
|
|
Date: May 13, 2025 |
|
|
|